Literature DB >> 15882539

In clinical practice, masked hypertension is as common as isolated clinic hypertension: predominance of younger men.

Iddo Z Ben-Dov1, Liora Ben-Arie, Judith Mekler, Michael Bursztyn.   

Abstract

BACKGROUND: The prevalence and implications of masked hypertension are under investigation. The aim of this study was to investigate the clinical characteristics associated with masked hypertension in subjects referred for ambulatory blood pressure (BP) monitoring.
METHODS: We analyzed 1494 BP monitoring sessions. A subject was considered to have isolated clinic hypertension if clinic BP was > or =140/90 mmHg and awake BP was <135/85 mmHg. Masked hypertension was diagnosed when clinic BP was <140/90 mmHg and awake BP was > or =135/85 mmHg.
RESULTS: Of 1494 individuals, 16% had normal BP, 11% had isolated clinic hypertension, 61% had hypertension, and 11% had masked hypertension. Subjects with masked hypertension were younger and more likely to be male than subjects with isolated clinic hypertension, and their awake heart rate was significantly higher. A negative correlation was found between the awake-clinic systolic BP difference and clinic systolic BP (r = -0.7, P < .0001). The reproducibility of the masking phenomenon was comparable to that of other variables.
CONCLUSIONS: In a group of consecutive subjects referred for ambulatory BP monitoring, masked hypertension was found to be as common as isolated clinic hypertension. Masking was correlated with male sex, young age, and higher awake heart rate, thus suggesting a causal relationship with greater daytime physical activity. The linear association of the masking and the white-coat effects to clinic BP suggests that regression toward the mean may partially explain these phenomena.

Entities:  

Mesh:

Year:  2005        PMID: 15882539     DOI: 10.1016/j.amjhyper.2004.11.036

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

Review 1.  Masked hypertension: a common but insidious presentation of hypertension.

Authors:  D W McKay; Martin G Myers; Peter Bolli; Arun Chockalingam
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

2.  Ambulatory not office blood pressure predicts mortality also in the elderly.

Authors:  Michael Bursztyn
Journal:  J Hum Hypertens       Date:  2019-07-26       Impact factor: 3.012

3.  Levels of office blood pressure and their operating characteristics for detecting masked hypertension based on ambulatory blood pressure monitoring.

Authors:  Anthony J Viera; Feng-Chang Lin; Laura A Tuttle; Daichi Shimbo; Keith M Diaz; Emily Olsson; Kristin Stankevitz; Alan L Hinderliter
Journal:  Am J Hypertens       Date:  2014-06-04       Impact factor: 2.689

4.  Frequency and related factors of masked hypertension at a worksite in Korea.

Authors:  Sang-Kyu Kim; Jun-Ho Bae; Dung-Young Nah; Dong-Wook Lee; Tae-Yoon Hwang; Kyeong-Soo Lee
Journal:  J Prev Med Public Health       Date:  2011-05

Review 5.  Utility of ambulatory blood pressure monitoring in children and adolescents.

Authors:  John W Graves; Mohammed Mahdi Althaf
Journal:  Pediatr Nephrol       Date:  2006-07-06       Impact factor: 3.714

6.  Reproducibility of masked uncontrolled hypertension detected through home blood pressure monitoring.

Authors:  Jessica Barochiner; María Lourdes Posadas Martínez; Rocío Martínez; Diego Giunta
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-19       Impact factor: 3.738

7.  Impact of Ambulatory Blood Pressure Monitoring on Reclassification of Hypertension Prevalence and Control in Older People in Spain.

Authors:  José R Banegas; Juan J de la Cruz; Auxiliadora Graciani; Esther López-García; Teresa Gijón-Conde; Luis M Ruilope; Fernando Rodriguez-Artalejo
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-16       Impact factor: 3.738

Review 8.  The natural history of hypertension: prehypertension or masked hypertension?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

Review 9.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Examination of Several Physiological and Psychosocial Factors Potentially Associated With Masked Hypertension Among Low-Risk Adults.

Authors:  Anthony J Viera; Feng-Chang Lin; Laura A Tuttle; Emily Olsson; Susan S Girdler; Alan L Hinderliter
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-28       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.